March 02, 2026 a 11:43 am
BDX: Fundamental Ratio Analysis - Becton, Dickinson and Company
Becton, Dickinson and Company (BDX) is a dominant player in the healthcare sector, offering a diverse range of medical supplies and devices. The company's fundamentals indicate a stable position with potential for steady growth. Its strong presence in the market and innovative product lines make it a viable investment option in the medical industry.
Fundamental Rating
The company's fundamental ratings reveal moderate strengths and some areas for improvement.
| Category | Score | |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 3 | |
| Return on Assets | 3 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
Historical Rating
The historical scores indicate a consistent performance in recent ratings.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-02-27 | 3 | 5 | 3 | 3 | 1 | 2 | 3 |
| N/A | 0 | 5 | 3 | 3 | 1 | 2 | 3 |
Analyst Price Targets
The analyst price targets reflect a positive outlook with a consensus among analysts.
| High | Low | Median | Consensus |
|---|---|---|---|
| $215 | $170 | $202 | $193.8 |
Analyst Sentiment
The analyst sentiment appears to be balanced, leaning towards buying recommendations.
| Recommendation | Count | |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 16 | |
| Hold | 16 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Becton, Dickinson and Company presents a solid investment opportunity in the healthcare sector with steady growth potential. The company's financial ratios indicate areas of strength, though some financial metrics such as debt-to-equity need attention. Analyst sentiment and price targets suggest optimism with a consensus on buying. Investors should consider potential market volatility and the impact of global healthcare trends on the company's performance.